As development timelines shorten, flexible and reproducible target recognition has become essential.
At Synbio Technologies, we provide a fully integrated aptamer development platform designed to deliver high-performance, application-ready binding solutions—helping teams move efficiently from target identification to real-world deployment.

 
Why Aptamers?
Compared with conventional antibodies, aptamers offer distinct advantages across a wide range of targets, including proteins, viruses, cells, and small molecules:
  • Faster development via in vitro SELEX (weeks, no animal systems)
  • Lower cost and higher reproducibility through chemical synthesis
  • Easy engineering with labels or functional modifications
Our End-to-End Aptamer Services
  • Rational target and library design
  • High-quality library synthesis
  • High-throughput selection and enrichment
  • Binding and specificity validation
All stages are supported by proprietary bioinformatics and screening technologies to ensure reliability and performance.

Whether your focus is targeted therapeutics, diagnostics, or advanced research tools, we tailor each aptamer to meet your specific technical and application requirements.

We would be pleased to connect and learn more about your goals.
 
Looking for more? These services might be just what you need:
DNA Synthesis RNA Synthesis
Oligo Synthesis Antisense Oligonucleotides
Synbio Technologies LinkedIn X Facebook Facebook

Thank you for connecting with us! Click "Subscribe" to receive valuable insights and news. If you prefer not to receive further emails, just hit "Unsubscribe" — your choice is always respected.
Synbio Technologies LLC
9 Deer Prk Dr., Suite J-25, Monmouth Junction, NJ 08852, USA